Scott Wagner Joins GoodRx Board: A Strategic Boost for the Company's Future

In a strategic move that signals a commitment to growth and innovation, GoodRx Holdings, Inc. (Nasdaq: GDRX) has appointed Scott Wagner to its Board of Directors, effective January 21, 2025. Wagner, who previously served as the company's Interim Chief Executive Officer from April 2023 to January 2025, brings a wealth of experience and a deep understanding of the GoodRx business to his new role as Co-Chair of the Board. As the former CEO, President, COO, and CFO of GoDaddy, Wagner has a proven track record of driving growth and expansion, making him an ideal fit for GoodRx's strategic vision.

Wagner's appointment coincides with the resignation of Simon Patterson from the board, including his positions on the Nominating and Corporate Governance Committee and Innovation Committee. This change in leadership is expected to bring fresh perspectives and a renewed focus on innovation and strategic growth for GoodRx.

As Co-Chair of the Board, Wagner will work alongside existing Co-Chair Trevor Bezdek to drive forward the strategic vision he helped lay out for the company over the last year and a half. His extensive leadership experience, particularly at GoDaddy, aligns perfectly with GoodRx's mission to make healthcare more affordable and accessible. Wagner's passion for mission-driven consumer tech brands, coupled with his ability to deliver new experiences that provide exceptional value to consumers, healthcare providers, and manufacturers, makes him an invaluable addition to the GoodRx team.